Outpatient Oncology Infusion Market Report 2026

Outpatient Oncology Infusion Market Overview

• Outpatient Oncology Infusion market size has reached to $14.02 billion in 2025 • Expected to grow to $20.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Increasing Prevalence Of Cancer Cases Driving The Growth Of The Market Due To Aging Populations And Rising Cancer Risk • Market Trend: Advancements In Smart Infusion Technology For Improved Safety And Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Outpatient Oncology Infusion Market?

Outpatient oncology infusion refers to the administration of cancer-fighting medications to patients in a non-hospital setting, such as infusion centers or clinics. Its purpose is to provide effective, convenient, and cost-efficient cancer treatment while allowing patients to avoid lengthy hospital stays. The main product types of outpatient oncology infusion include infusion pumps, intravenous sets, intravenous cannulas, and needleless connectors. Infusion pumps are medical devices used to deliver controlled amounts of fluids, such as medications or nutrients, into a patient’s body over a specific period. These devices provide various therapies such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They are used in different applications, including lung cancer, liver cancer, breast cancer, prostate cancer, and others, and by various end users such as hospitals, outpatient clinics, and home care settings.

What Is The Outpatient Oncology Infusion Market Growth Forecast?

The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $20.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology treatments, rising investments in outpatient infusion centers, expansion of home-compatible infusion technologies, growing focus on cost-efficient cancer care, increasing integration of digital oncology monitoring. Major trends in the forecast period include increasing shift toward outpatient cancer treatment models, rising adoption of targeted and immunotherapies, growing use of smart infusion pumps, expansion of ambulatory infusion centers, enhanced focus on patient-centric oncology care.

Global Outpatient Oncology Infusion Market Segmentation

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors 2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy 3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers 4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings Subsegments: 1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps 2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets 3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas 4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

What Is The Driver Of The Outpatient Oncology Infusion Market?

The increasing prevalence of cancer cases is expected to propel the growth of the outpatient oncology infusion market going forward. Cancer is a group of complex diseases marked by the uncontrolled growth of abnormal cells, which can invade surrounding tissues and spread to other areas of the body. The prevalence of cancer cases is increasing primarily due to aging populations worldwide, as the risk of developing cancer rises significantly with age. Outpatient oncology infusion is used to administer cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical setting without requiring hospital admission, allowing patients to receive care while maintaining their daily routines. For instance, in April 2024, according to Macmillan Cancer Support, a UK-based charity providing practical, emotional, and financial support to people affected by cancer, it is projected that the number of individuals living with cancer in the UK will exceed 3 million presently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer cases is driving the growth of the outpatient oncology infusion industry.

Key Players In The Global Outpatient Oncology Infusion Market

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Global Outpatient Oncology Infusion Market Trends and Insights

Major companies operating in the outpatient oncology infusion market are focusing on technological advancement in infusion systems, such as next-generation smart infusion pumps to enhance medication safety and streamline chemotherapy delivery. Next-generation smart infusion pumps refer to digitally connected devices with advanced dose-error reduction software, integrated drug libraries, and real-time connectivity to minimize errors and standardize oncology treatments. For instance, in April 2024, Baxter International Inc., a US-based medical technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large-volume infusion pump, making it available for U.S. ordering. The integrated hardware-software system delivers precise large-volume infusions with embedded safety checks, dose-library enforcement, and connectivity for remote management. Baxter highlights advanced safety architecture, improved usability, and compatibility with its broader infusion ecosystem. The pump is suited for outpatient oncology infusion centers, ambulatory clinics, and hospitals, offering benefits such as enhanced dosing accuracy, streamlined nursing workflows, and reduced delays or adverse events during chemotherapy administration.

What Are Latest Mergers And Acquisitions In The Outpatient Oncology Infusion Market?

In December 2024, Cardinal Health, a US-based healthcare products, services, and distribution company, acquired Integrated Oncology Network (ION) for an undisclosed amount. With this acquisition, Cardinal Health aims to expand its specialty-care footprint by integrating ION’s more than 50 community-based oncology and urology practice sites across 10 U.S. states into its oncology alliance network, thereby enhancing its service offerings, broadening provider reach, and strengthening value-based care delivery across the cancer care continuum. Integrated Oncology Network is a US-based healthcare network that delivers a full spectrum of oncology and urology care, including medical oncology, radiation oncology, diagnostic testing, surgical oncology, and ancillary services, through its community-based practice sites.

Regional Outlook

North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Outpatient Oncology Infusion Market?

The outpatient oncology infusion market consists of revenues earned by entities by providing services such as hormone therapy infusions, supportive care infusions, patient monitoring, patient education, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The outpatient oncology infusion market also includes sales of biosimilars, immunotherapy agents, supportive care drugs, infusion bags, IV poles, and stands. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Outpatient Oncology Infusion Market Report 2026?

The outpatient oncology infusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the outpatient oncology infusion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.